StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$333.25+1.09 (+0.33%)

Close on Nov 18, 2026Market cap $15.91BP/E –Yield –

Charles River Laboratories International pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Charles River Laboratories International's pe ratio was 403.2× on Nov 11, 2026, against 24.4× a year earlier. Over the last 5 years it ranged from 17.9× to 826.5×, with a median of 28.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026403.2×−189.9
2025Apr 30, 2025593.1×+570.1
2024Dec 31, 202423.0×−2.6
2023Dec 29, 202325.6×−0.1
2022Dec 30, 202225.7×−23.0
2021Dec 31, 202148.7×+7.0
2020Dec 31, 202041.6×+8.9
2019Dec 31, 201932.8×−8.1
2018Dec 31, 201840.9×+14.2
2017Dec 29, 201726.7×+1.0
2016Dec 30, 201625.7×−0.8
2015Dec 31, 201526.4×+0.9
2014Dec 31, 201425.6×+0.4
2013Dec 31, 201325.1×+8.0
2012Dec 31, 201217.1×−73.4
2011Jan 31, 201190.5×+6.6
2010Dec 31, 201083.8×–

More Charles River Laboratories International figures

See a number that looks wrong?